IL201166A - שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלה - Google Patents
שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלהInfo
- Publication number
- IL201166A IL201166A IL201166A IL20116609A IL201166A IL 201166 A IL201166 A IL 201166A IL 201166 A IL201166 A IL 201166A IL 20116609 A IL20116609 A IL 20116609A IL 201166 A IL201166 A IL 201166A
- Authority
- IL
- Israel
- Prior art keywords
- cells
- scs
- undifferentiated
- culture system
- suspension
- Prior art date
Links
- 210000000130 stem cell Anatomy 0.000 title claims description 195
- 239000000725 suspension Substances 0.000 title claims description 95
- 238000000034 method Methods 0.000 title claims description 61
- 210000001778 pluripotent stem cell Anatomy 0.000 title claims description 12
- 210000004027 cell Anatomy 0.000 claims description 213
- 230000004069 differentiation Effects 0.000 claims description 105
- 239000002609 medium Substances 0.000 claims description 84
- 210000001082 somatic cell Anatomy 0.000 claims description 50
- 210000002744 extracellular matrix Anatomy 0.000 claims description 34
- 210000002966 serum Anatomy 0.000 claims description 34
- 230000001537 neural effect Effects 0.000 claims description 33
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 32
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 32
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 24
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 22
- 239000002243 precursor Substances 0.000 claims description 22
- 108010085895 Laminin Proteins 0.000 claims description 21
- 230000002269 spontaneous effect Effects 0.000 claims description 21
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 18
- 230000007774 longterm Effects 0.000 claims description 17
- 210000002569 neuron Anatomy 0.000 claims description 17
- 230000008093 supporting effect Effects 0.000 claims description 17
- 238000012423 maintenance Methods 0.000 claims description 15
- 102000045246 noggin Human genes 0.000 claims description 13
- 108700007229 noggin Proteins 0.000 claims description 13
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 12
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 12
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 12
- 239000013589 supplement Substances 0.000 claims description 12
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 11
- 238000004115 adherent culture Methods 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 102000003693 Hedgehog Proteins Human genes 0.000 claims description 9
- 108090000031 Hedgehog Proteins Proteins 0.000 claims description 9
- 229930182555 Penicillin Natural products 0.000 claims description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 9
- 230000003291 dopaminomimetic effect Effects 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 229940049954 penicillin Drugs 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000012679 serum free medium Substances 0.000 claims description 9
- 229960005322 streptomycin Drugs 0.000 claims description 9
- 108010067306 Fibronectins Proteins 0.000 claims description 7
- 102000016359 Fibronectins Human genes 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 239000005557 antagonist Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000004083 survival effect Effects 0.000 claims description 7
- 108010023082 activin A Proteins 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 6
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 5
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 210000001178 neural stem cell Anatomy 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 230000000921 morphogenic effect Effects 0.000 claims description 3
- 230000023895 stem cell maintenance Effects 0.000 claims description 3
- 102100038367 Gremlin-1 Human genes 0.000 claims description 2
- 101001032872 Homo sapiens Gremlin-1 Proteins 0.000 claims description 2
- 102000006533 chordin Human genes 0.000 claims description 2
- 108010008846 chordin Proteins 0.000 claims description 2
- 239000003797 essential amino acid Substances 0.000 claims description 2
- 235000020776 essential amino acid Nutrition 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 8
- 229960003966 nicotinamide Drugs 0.000 claims 4
- 235000005152 nicotinamide Nutrition 0.000 claims 4
- 239000011570 nicotinamide Substances 0.000 claims 4
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 3
- 102000007072 Nerve Growth Factors Human genes 0.000 claims 3
- 239000000306 component Substances 0.000 description 21
- 238000004114 suspension culture Methods 0.000 description 21
- 210000001671 embryonic stem cell Anatomy 0.000 description 20
- 210000002257 embryonic structure Anatomy 0.000 description 16
- 210000002459 blastocyst Anatomy 0.000 description 15
- 210000002242 embryoid body Anatomy 0.000 description 15
- 230000001939 inductive effect Effects 0.000 description 15
- 239000003550 marker Substances 0.000 description 15
- 238000004113 cell culture Methods 0.000 description 14
- 238000012258 culturing Methods 0.000 description 13
- 230000000877 morphologic effect Effects 0.000 description 13
- 238000000338 in vitro Methods 0.000 description 12
- 102100035290 Fibroblast growth factor 13 Human genes 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
- 210000001109 blastomere Anatomy 0.000 description 9
- 210000001259 mesencephalon Anatomy 0.000 description 9
- 230000000644 propagated effect Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000009795 derivation Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 210000001900 endoderm Anatomy 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000035755 proliferation Effects 0.000 description 7
- 230000009469 supplementation Effects 0.000 description 7
- 108010059616 Activins Proteins 0.000 description 6
- 102000005606 Activins Human genes 0.000 description 6
- 206010043276 Teratoma Diseases 0.000 description 6
- 239000000488 activin Substances 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 238000011031 large-scale manufacturing process Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 210000003716 mesoderm Anatomy 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 102000003956 Fibroblast growth factor 8 Human genes 0.000 description 5
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 208000012868 Overgrowth Diseases 0.000 description 5
- 210000003981 ectoderm Anatomy 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 210000001654 germ layer Anatomy 0.000 description 5
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 108010057417 polysialyl neural cell adhesion molecule Proteins 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000000392 somatic effect Effects 0.000 description 5
- 102000007469 Actins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000005064 dopaminergic neuron Anatomy 0.000 description 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
- 230000003371 gabaergic effect Effects 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000004498 neuroglial cell Anatomy 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001550 testis Anatomy 0.000 description 4
- 238000001665 trituration Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 description 3
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 3
- 102000008730 Nestin Human genes 0.000 description 3
- 108010088225 Nestin Proteins 0.000 description 3
- 102000007354 PAX6 Transcription Factor Human genes 0.000 description 3
- 101710150336 Protein Rex Proteins 0.000 description 3
- 238000011579 SCID mouse model Methods 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004243 Tubulin Human genes 0.000 description 3
- 108090000704 Tubulin Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 210000003953 foreskin Anatomy 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 210000000472 morula Anatomy 0.000 description 3
- 210000005055 nestin Anatomy 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 230000001902 propagating effect Effects 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 2
- 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 2
- 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 108010032788 PAX6 Transcription Factor Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- CJGYSWNGNKCJSB-YVLZZHOMSA-M [(4ar,6r,7r,7ar)-6-[6-(butanoylamino)purin-9-yl]-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate Chemical compound C([C@H]1O2)OP([O-])(=O)O[C@H]1[C@@H](OC(=O)CCC)[C@@H]2N1C(N=CN=C2NC(=O)CCC)=C2N=C1 CJGYSWNGNKCJSB-YVLZZHOMSA-M 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000003125 immunofluorescent labeling Methods 0.000 description 2
- 238000012744 immunostaining Methods 0.000 description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
- 108010028309 kalinin Proteins 0.000 description 2
- 238000004264 monolayer culture Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004017 serum-free culture medium Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010374 somatic cell nuclear transfer Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 101100016215 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celF gene Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- 101100399280 Bacillus subtilis (strain 168) licH gene Proteins 0.000 description 1
- 101100454433 Biomphalaria glabrata BG01 gene Proteins 0.000 description 1
- 101100454434 Biomphalaria glabrata BG04 gene Proteins 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 1
- 101100059891 Escherichia coli (strain K12) chbF gene Proteins 0.000 description 1
- 101150021185 FGF gene Proteins 0.000 description 1
- 102100031361 Fibroblast growth factor 20 Human genes 0.000 description 1
- 102100024802 Fibroblast growth factor 23 Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000846532 Homo sapiens Fibroblast growth factor 20 Proteins 0.000 description 1
- 101001051973 Homo sapiens Fibroblast growth factor 23 Proteins 0.000 description 1
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100309601 Mus musculus Scd3 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000012580 N-2 Supplement Substances 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- 101150081664 PAX6 gene Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 102000052651 Pancreatic hormone Human genes 0.000 description 1
- 101800001268 Pancreatic hormone Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 206010043275 Teratogenicity Diseases 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 101710119641 Trypsin-6 Proteins 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000002771 cell marker Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 230000000848 glutamatergic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 102000046645 human LIF Human genes 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
- 108010038862 laminin 10 Proteins 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012913 medium supplement Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- 230000014511 neuron projection development Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000004025 pancreas hormone Substances 0.000 description 1
- 229940032957 pancreatic hormone Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000001776 parthenogenetic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011536 re-plating Methods 0.000 description 1
- 230000008672 reprogramming Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000003523 substantia nigra Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 231100000211 teratogenicity Toxicity 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL201166A IL201166A (he) | 2007-04-02 | 2009-09-24 | שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלה |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/730,560 US8597947B2 (en) | 2004-12-29 | 2007-04-02 | Undifferentiated stem cell culture systems |
| PCT/IL2008/000460 WO2008120218A2 (en) | 2007-04-02 | 2008-04-02 | Undifferentiated stem cell culture systems |
| IL201166A IL201166A (he) | 2007-04-02 | 2009-09-24 | שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלה |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL201166A0 IL201166A0 (en) | 2010-05-17 |
| IL201166A true IL201166A (he) | 2014-03-31 |
Family
ID=42335747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL201166A IL201166A (he) | 2007-04-02 | 2009-09-24 | שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלה |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL201166A (he) |
-
2009
- 2009-09-24 IL IL201166A patent/IL201166A/he active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL201166A0 (en) | 2010-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8940537B2 (en) | Undifferentiated stem cell culture systems | |
| JP7357086B2 (ja) | 多能性幹細胞を培養するための新規な方法および培養培地 | |
| JP7383069B2 (ja) | 多能性幹細胞を未分化状態で培養する培地、細胞培養および方法 | |
| CN101233226B (zh) | 人胚胎干细胞的悬浮培养物 | |
| ES2665434T3 (es) | Diferenciación de células madre pluripotentes usando células alimentadoras humanas | |
| US20250027040A1 (en) | Methods for differentiating cells | |
| EP3192865B1 (en) | Single pluripotent stem cell culture | |
| US20090104695A1 (en) | Stem Cells Culture Systems | |
| EP1302536A2 (en) | Embryonic stem cells and neural progenitor cells derived therefrom | |
| AU2025238003A1 (en) | Preparation of retinal pigment epithelium cells | |
| AU2016303631B2 (en) | Preparation of photoreceptors for the treatment of retinal diseases | |
| Chaddah et al. | Clonal neural stem cells from human embryonic stem cell colonies | |
| Choi et al. | A novel feeder-free culture system for expansion of mouse spermatogonial stem cells | |
| Takada et al. | Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations | |
| US20100129910A1 (en) | Cell matrix related compositions and their use for generating embryoid bodies | |
| Liu et al. | Derivation of human embryonic stem cell lines without any exogenous growth factors | |
| US20230313127A1 (en) | Compositions and methods for embryonic stem cell expansion | |
| US20230081733A1 (en) | Methods for preparing keratinocytes | |
| Wu et al. | Derivation and characterization of human embryonic stem cell lines from the Chinese population | |
| IL201166A (he) | שיטות לגידול תאי אב בלתי ממויינים פלוריפוטנטיים במצב בלתי ממויין מערכות גידול המכילים תרחיף של תאי אב במצב בלתי ממויין ושימוש במערכות גידול אלה | |
| CN101517069A (zh) | 由人类胚泡来源的干细胞衍生的多能心脏前体细胞新种群 | |
| Zhang et al. | Feeder layer-and serum-free culture of rhesus monkey embryonic stem cells | |
| OJALA | Establishing and optimizing feeder cell-free culture methods for human | |
| Tuomisto | Component screening for novel xeno-free medium for human embryonic stem cells | |
| HK1239739A1 (en) | Single pluripotent stem cell culture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |